We studied the mechanisms for the altered fatty acid composition in erythrocytes (RBCs) derived from streptozocin-induced diabetic (STZ-D) rats. After 3-wk duration of diabetes, blood glucose, plasma triglyceride, and plasma free–fatty acid levels were all significantly increased. In the diabetic platelet-poor plasma (PPP), the most significant increases in free fatty acids were stearate, linoleate, eicosatrienoate (n-6), and docosahexaenoate (n-3). Fatty acid composition of RBC phospholipids was also altered, with significant decreases in arachidonate, docosatetraenoate (n-6), and docosapentaenoate (n-6) and increases in linoleate and docosahexaenoate. Insulin treatment of the diabetic rats resulted in normalization of docosapentaenoate, arachidonate, and linoleate levels in RBC phospholipids but not of docosahexaenoate or docosatetraenoate levels. The incorporation of [5,6,8,9,11,12,14,15-3H]arachidonate into diabetic RBC phospholipids was significantly decreased compared with the corresponding control RBC, regardless of the incubation medium used, which was the PPP derived either from the control or diabetic rats. Therefore, the decreased incorporation of [5,6,8,9,11,12,14,15-3H]arachidonate into diabetic RBC phospholipids was independent of the altered lipid composition of the PPP incubation media. Furthermore, the decreased incorporation was not specific for arachidonate, because the incorporation of other long-chain fatty acids such as [9,10-3H]oleate, [1-14C]palmitate, [2-14C]eicosatrienoate (n-6), and [1-14C]linoleate into RBC phospholipids was also comparably decreased. More important, the decreased fatty acid incorporations were reversed by insulin treatment of the diabetic rat. Our results indicate that the altered free–fatty acid composition in the diabetic plasma might not entirely account for the altered fatty acid composition of diabetic RBC phospholipids, and that the decreased incorporation or uptake of these fatty acids into the diabetic RBCs may contribute to some of these changes.
Skip Nav Destination
Article navigation
Original Articles|
December 01 1991
Decreased Incorporation of Long-Chain Fatty Acids into Erythrocyte Phospholipids of STZ-D Rats
An Quoc Dang;
An Quoc Dang
John L. McClellan Memorial Veterans Hospital and Department of Medicine, University of Arkansas for Medical Sciences
Little Rock, Arkansas
Search for other works by this author on:
Fred H Faas;
Fred H Faas
John L. McClellan Memorial Veterans Hospital and Department of Medicine, University of Arkansas for Medical Sciences
Little Rock, Arkansas
Search for other works by this author on:
Sunita M Jethmalani;
Sunita M Jethmalani
John L. McClellan Memorial Veterans Hospital and Department of Medicine, University of Arkansas for Medical Sciences
Little Rock, Arkansas
Search for other works by this author on:
William J Carter
William J Carter
John L. McClellan Memorial Veterans Hospital and Department of Medicine, University of Arkansas for Medical Sciences
Little Rock, Arkansas
Search for other works by this author on:
Address correspondence and reprint requests to A.Q. Dang, PhD, John L. McClellan Memorial Veterans Hospital, Medical Research 151 LR, Little Rock, AR 72205.
Diabetes 1991;40(12):1645–1651
Article history
Received:
January 25 1991
Revision Received:
August 27 1991
Accepted:
August 27 1991
PubMed:
1756905
Citation
An Quoc Dang, Fred H Faas, Sunita M Jethmalani, William J Carter; Decreased Incorporation of Long-Chain Fatty Acids into Erythrocyte Phospholipids of STZ-D Rats. Diabetes 1 December 1991; 40 (12): 1645–1651. https://doi.org/10.2337/diab.40.12.1645
Download citation file:
24
Views